Lombard Odier Asset Management (USA)’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-33,362
| Closed | -$164K | – | 345 |
|
|
2024
Q1 | $164K | Buy |
+33,362
| New | +$164K | ﹤0.01% | 208 |
|
|
2023
Q1 | – | Sell |
-11,177
| Closed | -$206K | – | 304 |
|
|
2022
Q4 | $206K | Buy |
+11,177
| New | +$206K | 0.01% | 181 |
|
|
2016
Q4 | – | Sell |
-21,611
| Closed | -$350K | – | 217 |
|
|
2016
Q3 | $350K | Sell |
21,611
-904
| -4% | -$14.6K | 0.03% | 189 |
|
|
2016
Q2 | $306K | Buy |
22,515
+6,320
| +39% | +$85.9K | 0.04% | 174 |
|
|
2016
Q1 | $283K | Sell |
16,195
-214,016
| -93% | -$3.74M | 0.04% | 144 |
|
|
2015
Q4 | $7.86M | Buy |
230,211
+5,211
| +2% | +$178K | 0.76% | 55 |
|
|
2015
Q3 | $6.7M | Sell |
225,000
-25,000
| -10% | -$744K | 0.58% | 52 |
|
|
2015
Q2 | $8M | Sell |
250,000
-28,568
| -10% | -$914K | 0.57% | 42 |
|
|
2015
Q1 | $5.78M | Buy |
278,568
+27,963
| +11% | +$580K | 0.46% | 73 |
|
|
2014
Q4 | $4.25M | Buy |
250,605
+50,710
| +25% | +$859K | 0.29% | 84 |
|
|
2014
Q3 | $3.86M | Buy |
199,895
+49,895
| +33% | +$964K | 0.27% | 89 |
|
|
2014
Q2 | $5.1M | Buy |
150,000
+50,000
| +50% | +$1.7M | 0.27% | 91 |
|
|
2014
Q1 | $3.15M | Buy |
+100,000
| New | +$3.15M | 0.12% | 131 |
|